Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Other Non-Current Liabilities (2016 - 2025)

Fresenius Medical Care AG (FMS) has 14 years of Other Non-Current Liabilities data on record, last reported at $1.2 billion in Q4 2022.

  • For Q4 2022, Other Non-Current Liabilities rose 101.4% year-over-year to $1.2 billion; the TTM value through Dec 2022 reached $1.2 billion, up 101.4%, while the annual FY2022 figure was $1.2 billion, 108.05% up from the prior year.
  • Other Non-Current Liabilities reached $1.2 billion in Q4 2022 per FMS's latest filing, up from $599.8 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $1.2 billion in Q4 2022 and bottomed at $599.8 million in Q4 2021.
  • Average Other Non-Current Liabilities over 5 years is $839.5 million, with a median of $710.3 million recorded in 2018.
  • Peak YoY movement for Other Non-Current Liabilities: tumbled 39.96% in 2018, then soared 101.4% in 2022.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $710.3 million in 2018, then decreased by 3.86% to $682.9 million in 2019, then surged by 45.97% to $996.8 million in 2020, then tumbled by 39.83% to $599.8 million in 2021, then surged by 101.4% to $1.2 billion in 2022.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $1.2 billion in Q4 2022, $599.8 million in Q4 2021, and $996.8 million in Q4 2020.